ArticleSkin appendage disorders2021
Bibliometric Analysis of the 50 Most Cited Publications in Hidradenitis Suppurativa.
Article in Skin appendage disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 13 citations in OpenAlex.
- Research Situation, Hotspots, and Global Trends in Laser Treatment of Acne Scars: A Bibliometric Analysis of Related Research From 2014 to 2024.Journal of cosmetic dermatology · 2025Article
- Research hotspots in urticaria: A bibliometric study of the top 100 most cited articles.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024Article
- Bibliometric analyses of publications in the field of restless legs syndrome.Acta neurologica Belgica · 2023Article
- Hidradenitis suppurativa publication trends from Latin America from 2009 to 2019: A bibliometric analysis.International journal of women's dermatology · 2022Article
- Bibliometric Analysis of Hidradenitis Suppurativa Publication Trends from Asia and Australasia.Skin appendage disorders · 2022Article
- Top 100 most-cited publications in hidradenitis suppurativa: An updated bibliometric analysis.Frontiers in medicine · 2022Article
- The top 100 most cited articles in the last two decades of atopic dermatitis: A bibliometric analysis.Frontiers in immunology · 2022Article
- Bibliometric Analysis of the 50 Most Cited Publications in Epidermolysis Bullosa.Pediatric dermatologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHidradenitis suppurativa (HS) has historically been a neglected disease. However, research in this field has grown exponentially in the past decade.
methodsThe top-cited HS articles from 1950 to 2020 were analyzed for authorship, study topic, study design, and senior author country of origin.
resultsWe found that nearly half of the top 50 cited articles were published in the last decade, with a recent increase in the number of highly cited randomized controlled trials. Medical treatment is the most cited topic, with more attention on biologics over time. The past decade has seen an increase in highly cited articles on HS comorbidities, pathogenesis, and clinical practice guidelines. There has been a predominance of highly cited HS research from Europe; highly cited studies from Africa, Asia, Australia, and South America are lacking.
conclusionsRecent advances in HS research have focused on investigating HS pathogenesis and drug development, highlighting disease comorbidities, and improving evidence-based care. Studies in pathogenesis have translated into a paradigm shift in medical treatment from antibiotics to incorporation of targeted therapies in recent years. Encouraging growth of HS research in countries outside of North America and Europe may help to optimize HS care globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.